Institutional
Alerce Investment Management, L.P.
CIK 0001844002
$56.8M
Reported AUM
5
Positions
Q4 2024
Period
2025-02-14
Filed
Editorial summary
Summary for Alerce Investment Management, L.P. · Q4 2024 is not yet generated. It will appear here after the next nightly run.
Portfolio · Q4 2024
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ANNX | ANNEXON INC | $5.27 | 8.44% | 108.16% | -68.81% | $38.0M | 66.89% | — | HELD |
| 2 | AKBA | AKEBIA THERAPEUTICS INC | $1.35 | 7.14% | -63.71% | -54.08% | $10.9M | 19.23% | — | HELD |
| 3 | VRNA | VERONA PHARMA PLC | — | — | — | — | $4.1M | 7.19% | — | HELD |
| 4 | AMWL | AMERICAN WELL CORP | $10.84 | 0.65% | 54.64% | -94.94% | $3.8M | 6.69% | — | HELD |
| 5 | WHWK | AADI BIOSCIENCE INC | $3.85 | 5.19% | 121.26% | -85.22% | $2K | 0.00% | — | HELD |
Source: SEC EDGAR · accession 0000895345-25-000069. 13F discloses long positions only — shorts, foreign equities, and options are excluded.